These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 968062)

  • 1. First experiences with a (15S)-15-methyl prostaglandin F2alpha vaginal device for termination of early first trimester pregnancy with serial sonographic observations.
    Duenhoelter JH; Santos-Ramos R
    Prostaglandins; 1976; 12 Suppl():135-45. PubMed ID: 968062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of silastic vaginal device containing (15S)-15 methyl prostaglandin F2 alpha methyl ester for early first trimester pregnancy termination.
    Robins J
    Prostaglandins; 1976; 12 Suppl():123-34. PubMed ID: 968061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination.
    Hendricks CH; Dingfelder JR; Gruber WS
    Prostaglandins; 1976; 12 Suppl():99-122. PubMed ID: 968068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravaginal 15 methyl prostaglandin F2alpha methyl ester in first and second trimester abortion.
    Dillon TF; Mootabar H; Phillips LL; Risk A
    Prostaglandins; 1976; 12 Suppl():81-98. PubMed ID: 968067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976).
    Southern EM
    Prostaglandins; 1976; 12 Suppl():147-52. PubMed ID: 788056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Induced abortion with intramuscular administration of 15(S)-15methyl-prostaglandin F 2 alpha].
    Halle H; Lau HU; Hengst P
    Zentralbl Gynakol; 1977; 99(9):537-40. PubMed ID: 560770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-amniotic administration of prostaglandin F 2 alpha, 12-methyl-prostaglandin F 2 alpha and hypertonic sodium chloride solution for induction of abortion in second-trimester pregnancy].
    Persianinov LS; Chernukha EA
    Zentralbl Gynakol; 1975; 97(19):1153-9. PubMed ID: 1189789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of second-trimester abortion with a single dose (40 mg) of intra-amniotic prostaglandin F2a.
    Grech ES; Chatterjee TK; Kaunda FW
    East Afr Med J; 1977 Jun; 54(6):306-13. PubMed ID: 923482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of early gestation with a vaginal polysiloxane device impregnated with (15S)-15 methyl prostaglandin F2alpha methylester.
    Brenner PF; Ballard C; Mishell DR
    Prostaglandins; 1977 Oct; 14(4):771-777. PubMed ID: 594379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The termination of human pregnancy with prostaglandin analogs.
    Gutknecht GD; Southern EM
    J Reprod Med; 1975 Sep; 15(3):93-6. PubMed ID: 1214255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of late first-trimester and early second-trimester gestations with intramuscular 15 (S)-15-methyl-prostaglandin F2alpha.
    Bolognese RJ; Corson SL
    J Reprod Med; 1976 Feb; 16(2):81-4. PubMed ID: 943540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2alpha methyl ester.
    Bygdeman M; Borell U; Leader A; Lundström V; Martin JN; Eneroth P; Gréen K
    Adv Prostaglandin Thromboxane Res; 1976; 2():693-704. PubMed ID: 983870
    [No Abstract]   [Full Text] [Related]  

  • 20. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.